carmustine has been researched along with Head and Neck Neoplasms in 6 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
Excerpt | Relevance | Reference |
---|---|---|
" Currently, SU101 in combination with cytotoxic agents is in late-stage clinical development for the treatment of cancers." | 1.31 | Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts. ( Cherrington, JM; Kabbinavar, F; Mann, E; Schwartz, DP; Shawver, LK; Slamon, DJ; Strawn, LM, 2000) |
"Metronidazole, 1." | 1.27 | Feasibility study of combining metronidazole with chemotherapy. ( Bélanger, R; Crook, AF; Heringer, R; Hopkins, HS; Hugenholtz, H; Maroun, JA; Richard, MT; Stewart, DJ; Yan, RC; Young, V, 1983) |
"Osseous, visceral, and cutaneous metastases responded equally well." | 1.26 | Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors. ( Klahr, C; Kolhouse, JF; Presant, CA, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stewart, DJ | 1 |
Maroun, JA | 1 |
Young, V | 1 |
Crook, AF | 1 |
Hopkins, HS | 1 |
Yan, RC | 1 |
Richard, MT | 1 |
Hugenholtz, H | 1 |
Bélanger, R | 1 |
Heringer, R | 1 |
Strawn, LM | 1 |
Kabbinavar, F | 1 |
Schwartz, DP | 1 |
Mann, E | 1 |
Shawver, LK | 1 |
Slamon, DJ | 1 |
Cherrington, JM | 1 |
Presant, CA | 2 |
Ratkin, G | 1 |
Klahr, C | 2 |
Brown, C | 1 |
Hill, GJ | 1 |
Johnson, RO | 1 |
Metter, G | 1 |
Wilson, WL | 1 |
Davis, HL | 1 |
Grage, T | 1 |
Fletcher, WS | 1 |
Golomb, FM | 1 |
Cruz, AB | 1 |
Slavik, M | 1 |
Kolhouse, JF | 1 |
6 other studies available for carmustine and Head and Neck Neoplasms
Article | Year |
---|---|
Feasibility study of combining metronidazole with chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Sq | 1983 |
Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Div | 2000 |
Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
Topics: Antineoplastic Agents; Bone Marrow; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Carmustine; | 1979 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |
Clinical studies with nitrosoureas in various solid tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Female; Genital Neoplasms, F | 1976 |
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors.
Topics: Adenocarcinoma; Adolescent; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Cyclophosp | 1976 |